The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

MLA

Tai-Ho Hung, et al. “The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.” International Journal of Molecular Sciences, vol. 22, Aug. 2021, p. 9440. EBSCOhost, https://doi.org/10.3390/ijms22179440.

APA

Tai-Ho Hung, Yang-Hui Huang, Yu-Shan Wu, Yan-Qing Li, Chung-Pu Wu, & Ya-Chen Chi. (2021). The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences, 22, 9440. https://doi.org/10.3390/ijms22179440

Chicago

Tai-Ho Hung, Yang-Hui Huang, Yu-Shan Wu, Yan-Qing Li, Chung-Pu Wu, and Ya-Chen Chi. 2021. “The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.” International Journal of Molecular Sciences 22 (August): 9440. doi:10.3390/ijms22179440.